• Mycobacterium tuberculosis and the response of its host
• 34 min
  1. The genetic structure of Mycobacterium tuberculosis - insights into genome organisation and evolution of the causative agent of tuberculosis

  • Dr. Roland Brosch
• 36 min
  2. The pathogenesis of tuberculosis

  • Dr. William R. Bishai
• 57 min
  3. Immune response and rational development of vaccines and biomarkers

  • Prof. Dr. Stefan H. E. Kaufmann
• 38 min
  4. Molecular mechanisms of drug resistance in M. tuberculosis

  • Dr. Daniela Cirillo
• The epidemiology of tuberculosis
• 40 min
  5. The basic epidemiology of tuberculosis (TB)

  • Dr. David Dowdy
• 34 min
  6. Global epidemiology of TB

  • Dr. Philippe Glaziou
• 48 min
  7. Social determinants of tuberculosis

  • Dr. Knut Lönnroth
• The control of tuberculosis
• 46 min
  8. Treatment of tuberculosis

  • Dr. Jean-Pierre Zellweger
• 32 min
  9. The End TB Strategy towards TB elimination 1

  • Dr. Mario Raviglione
• 52 min
  10. The End TB Strategy towards TB elimination 2

  • Dr. Mario Raviglione
• 38 min
  11. Financing TB care and control

  • Dr. Christopher Fitzpatrick
  • Dr. Andrea Pantoja
• 27 min
  12. Tuberculosis and COVID-19

  • Prof. Giovanni Battista Migliori
• 36 min
  13. Multidrug resistant tuberculosis (MDR-TB): an update

  • Dr. Simon Tiberi
• 49 min
  14. Impact of HIV on tuberculosis in the developing world and how to manage it

  • Prof. Anthony D. Harries
• 33 min
  15. Reaching the missing millions through public-private mix (PPM) for TB prevention and care

  • Ms. Hannah Monica Dias
• 39 min
  16. TB in children

  • Prof. Ben J. Marais
• 30 min
  17. Community engagement in tuberculosis care

  • Ms. Lana Syed
• 29 min
  18. India: the epicentre of global TB control

  • Dr. Madhukar Pai
• 23 min
  19. Community engagement in TB care

  • Dr. Haileyesus Getahun
• Research and development for new approaches in the control of tuberculosis
• 21 min
  20. Development of new regimens for tuberculosis

  • Dr. Zhenkun Ma
• 35 min
  21. Development, testing and introduction of new diagnostic tools for tuberculosis

  • Dr. Mark Perkins
• 69 min
  22. Pharmacometrics in tuberculosis

  • Prof. Charles A. Peloquin
• 29 min
  23. Extrapulmonary tuberculosis

  • Dr. Scott Heysell
• 27 min
  24. The role of surgery in tuberculosis management

  • Dr. Richard Zaleskis
• Archived Lectures *These may not cover the latest advances in the field
• 28 min
  25. The development of current treatments for tuberculosis

  • Dr. Andrew Nunn
• 47 min
  26. The pathogenesis of tuberculosis

  • Dr. William R. Bishai
• 34 min
  27. Basics of tuberculosis epidemiology

  • Prof. Frank Cobelens
• 40 min
  28. Drug resistance in tuberculosis and its public health management

  • Dr. Paul Nunn
• 57 min
  29. The international approach to the control of tuberculosis

  • Dr. Mario Raviglione
• 35 min
  30. Public-private mix for TB care and control

  • Dr. Mukund Uplekar

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. What do this people have in common?
3. Fight tuberculosis
4. TB mortality and disease rates in Netherlands
5. TB incidence
6. Lecture structure
7. 1. Natural history of TB disease
8. Disease manifestations
9. Predominant clinical presentations by age
10. Effect of CD4 count on clinical presentation
11. Incubation period
12. Survival of untreated TB
13. 2. Progression from latent TB to disease
14. Latent TB infection
15. Risk of TB disease is age dependent
16. Risk factors for progression to TB disease
17. HIV
18. Malnutrition
19. Diabetes
20. Tobacco smoking
21. 4. Transmission, infection and re-infection
22. Risk factors for TB transmission
23. TB transmission
24. Effect of UV light on transmission risk
25. Infectious aerosols and sputum smear grade
26. Infectiousness and smear status
27. Closeness of contact and TB transmission
28. Paris, 1910
29. Duration of infectiousness
30. Re-infection
31. 4. Quantifying the burden of TB
32. Measures of disease occurrence: incidence
33. Measures of disease occurrence: prevalence
34. Incidence and prevalence
35. Incidence, prevalence and notification rate
36. Deriving incidence from prevalence
37. Annual risk of TB infection (ARTI)
38. Styblo's rule
39. Styblo's rule: still valid?
40. Styblo's rule refuted
41. Case detection rate (CDR)
42. HIV reduces the duration of TB disease

Topics Covered

• Global distribution of tuberculosis
• Natural history
• Risk factors for progression from latent infection to tuberculosis disease
• Transmission, infection and re-infection
• Quantifying the burden of tuberculosis in human populations
• Impact of HIV on tuberculosis epidemiology

Links

Series:

• Tuberculosis

Categories:

• Microbiology

Therapeutic Areas:

• Infectious Diseases
• Respiratory Diseases

Talk Citation

Publication History

• Published on February 28, 2013
• Archived on November 28, 2021

Financial Disclosures

• Prof. Frank Cobelens has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.